123 related articles for article (PubMed ID: 16989613)
1. A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN.
Lee SJ; Arora R; Bull LM; Arduino RC; Garza L; Allan J; Kimata JT; Zhou P
AIDS Res Hum Retroviruses; 2006 Sep; 22(9):874-83. PubMed ID: 16989613
[TBL] [Abstract][Full Text] [Related]
2. CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1.
Wang JH; Janas AM; Olson WJ; KewalRamani VN; Wu L
J Virol; 2007 Mar; 81(5):2497-507. PubMed ID: 17151103
[TBL] [Abstract][Full Text] [Related]
3. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes.
van Montfort T; Nabatov AA; Geijtenbeek TB; Pollakis G; Paxton WA
J Immunol; 2007 Mar; 178(5):3177-85. PubMed ID: 17312166
[TBL] [Abstract][Full Text] [Related]
4. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.
Naarding MA; Ludwig IS; Groot F; Berkhout B; Geijtenbeek TB; Pollakis G; Paxton WA
J Clin Invest; 2005 Nov; 115(11):3256-64. PubMed ID: 16239964
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN.
Boggiano C; Manel N; Littman DR
J Virol; 2007 Mar; 81(5):2519-23. PubMed ID: 17182696
[TBL] [Abstract][Full Text] [Related]
6. A nonneutralizing anti-HIV-1 antibody turns into a neutralizing antibody when expressed on the surface of HIV-1-susceptible cells: a new way to fight HIV.
Lee SJ; Garza L; Yao J; Notkins AL; Zhou P
J Immunol; 2004 Oct; 173(7):4618-26. PubMed ID: 15383596
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes.
Balzarini J; Van Herrewege Y; Vermeire K; Vanham G; Schols D
Mol Pharmacol; 2007 Jan; 71(1):3-11. PubMed ID: 17056872
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.
Groot F; Geijtenbeek TB; Sanders RW; Baldwin CE; Sanchez-Hernandez M; Floris R; van Kooyk Y; de Jong EC; Berkhout B
J Virol; 2005 Mar; 79(5):3009-15. PubMed ID: 15709021
[TBL] [Abstract][Full Text] [Related]
9. DC-SIGN points the way to a novel mechanism for HIV-1 transmission.
Masso M
MedGenMed; 2003 May; 5(2):2. PubMed ID: 14603101
[TBL] [Abstract][Full Text] [Related]
10. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN.
Yu Kimata MT; Cella M; Biggins JE; Rorex C; White R; Hicks S; Wilson JM; Patel PG; Allan JS; Colonna M; Kimata JT
J Virol; 2002 Dec; 76(23):11827-36. PubMed ID: 12414925
[TBL] [Abstract][Full Text] [Related]
11. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
[TBL] [Abstract][Full Text] [Related]
12. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets.
Chaipan C; Soilleux EJ; Simpson P; Hofmann H; Gramberg T; Marzi A; Geier M; Stewart EA; Eisemann J; Steinkasserer A; Suzuki-Inoue K; Fuller GL; Pearce AC; Watson SP; Hoxie JA; Baribaud F; Pöhlmann S
J Virol; 2006 Sep; 80(18):8951-60. PubMed ID: 16940507
[TBL] [Abstract][Full Text] [Related]
13. The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?
Baribaud F; Doms RW; Pöhlmann S
Expert Opin Ther Targets; 2002 Aug; 6(4):423-31. PubMed ID: 12223058
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
[TBL] [Abstract][Full Text] [Related]
15. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission.
Wu L; Martin TD; Vazeux R; Unutmaz D; KewalRamani VN
J Virol; 2002 Jun; 76(12):5905-14. PubMed ID: 12021323
[TBL] [Abstract][Full Text] [Related]
16. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
Garcia-Vallejo JJ; Koning N; Ambrosini M; Kalay H; Vuist I; Sarrami-Forooshani R; Geijtenbeek TB; van Kooyk Y
Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
[TBL] [Abstract][Full Text] [Related]
17. DC-SIGN-mediated transfer of HIV-1 is compromised by the ability of Leishmania infantum to exploit DC-SIGN as a ligand.
Zhao C; Cantin R; Breton M; Papadopoulou B; Tremblay MJ
J Infect Dis; 2005 May; 191(10):1665-9. PubMed ID: 15838793
[TBL] [Abstract][Full Text] [Related]
18. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Garcia E; Escola JM; van Kooyk Y; Geijtenbeek TB; Piguet V
J Exp Med; 2004 Nov; 200(10):1279-88. PubMed ID: 15545354
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.
Ludwig IS; Lekkerkerker AN; Depla E; Bosman F; Musters RJ; Depraetere S; van Kooyk Y; Geijtenbeek TB
J Virol; 2004 Aug; 78(15):8322-32. PubMed ID: 15254204
[TBL] [Abstract][Full Text] [Related]
20. Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes.
Engering A; Van Vliet SJ; Geijtenbeek TB; Van Kooyk Y
Blood; 2002 Sep; 100(5):1780-6. PubMed ID: 12176900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
